A 29-year-old G2P1 woman with a known O-negative blood type delivers a male infant at 37 weeks of gestation via spontaneous vaginal delivery. Her first pregnancy two years ago was uncomplicated, and she does not recall receiving any injections after that delivery. Within 12 hours of birth, the neonate is noted to be lethargic with significant jaundice and pallor. Physical examination reveals hepatosplenomegaly. Initial laboratory results show a haemoglobin of 9.5 g/dL, a total bilirubin of 22 mg/dL (1.5 mg/dL direct), and a peripheral smear showing numerous spherocytes and nucleated red blood cells. The neonate's direct antiglobulin test (DAT) is strongly positive. The hemolysis observed in this neonate is most likely mediated by which of the following maternal antibodies that have crossed the placenta?

A 28-year-old man of Southeast Asian origin undergoes a health check-up. He is found to have mild anaemia with a haemoglobin of 11.2 g/dL and a markedly low mean corpuscular volume (MCV) of 68 fL. His red cell distribution width (RDW) is normal at 13.0%. A full iron panel is ordered, which reveals a serum ferritin of 300 µg/L and a transferrin saturation of 45%. The physician suspects a hemoglobinopathy. Which of the following is the most appropriate next test to confirm the suspected diagnosis?

A 12-hour-old neonate, born to an O-negative mother, is noted to have rapidly progressing jaundice and lethargy in the NICU. His blood type is confirmed to be O-positive, and his direct antiglobulin test (DAT) is positive. His total serum bilirubin is 28 mg/dL (480 µmol/L) with a direct bilirubin of 1.0 mg/dL. His haemoglobin has dropped to 7.0 g/dL. Despite being under intensive phototherapy for the past 4 hours, his bilirubin level continues to rise. What is the most appropriate next step in the management of this neonate?

A 47-year-old man, diagnosed with Chronic Myeloid leukaemia (CML) two years ago, is being followed up in the haematology clinic. He has been well-controlled on imatinib and is currently asymptomatic. A routine surveillance bone marrow aspirate and biopsy are performed. The biopsy confirms the presence of CML in the chronic phase with BCR-ABL1 positivity. However, it also reveals a distinct population of 40% mature-appearing lymphocytes. Flow cytometry of the aspirate shows these lymphocytes are monoclonal and express CD5, CD19, CD20, and CD23. Which of the following is the most likely additional diagnosis in this patient?

A 25-year-old male of Mediterranean descent presents to the clinic with a lifelong history of fatigue and pallor. On examination, he has scleral icterus and a spleen palpable 6 cm below the left costal margin. Initial laboratory investigations reveal a haemoglobin of 8.5 g/dL, a Mean Corpuscular Volume (MCV) of 65 fL, and a Red Cell Distribution Width (RDW) of 13% (normal range 12-15%). A peripheral blood smear demonstrates hypochromia, microcytosis, target cells, and coarse basophilic stippling. Iron studies show a serum iron of 190 mcg/dL (high), ferritin of 800 ng/mL (high), and transferrin saturation of 75% (high). Which of the following investigations is the most specific next step to establish the definitive diagnosis?

A 34-year-old woman presents to the clinic for advice regarding her risk of thrombosis. Her 58-year-old father and 38-year-old brother both have a history of unprovoked deep vein thrombosis (DVT). The patient herself is asymptomatic and has no significant past medical history. She is considering starting oral contraceptive pills for family planning. A thorough review of her family history reveals no other chronic illnesses, malignancies, or autoimmune disorders. She is concerned about her own risk and asks about potential underlying inherited conditions. What is the most common hereditary thrombophilia she is at risk for?

A 62-year-old female is diagnosed with Primary Myelofibrosis. She is experiencing debilitating fatigue, drenching night sweats, and symptomatic splenomegaly that causes significant abdominal discomfort and early satiety. Her risk stratification using the Dynamic International Prognostic Scoring System (DIPSS) places her in the intermediate-2 risk category. Her molecular testing is positive for a JAK2 V617F mutation. The decision is made to initiate therapy aimed at controlling her constitutional symptoms and reducing the size of her spleen. What is the most appropriate therapeutic agent to initiate for this patient's symptomatic disease?

A 31-year-old woman presents with persistent weakness. Her past medical history is significant for pulmonary tuberculosis treated six months ago. She is not taking any current medications. Laboratory results show a haemoglobin of 10.1 g/dL and an MCV of 72 fL. Iron studies are ordered and reveal a serum iron of 190 µg/dL, a TIBC of 200 µg/dL, and a serum ferritin of 800 ng/mL. A review of her peripheral blood smear confirms microcytic anaemia with target cells and coarse basophilic stippling. Sideroblastic anaemia is suspected. Which of the following investigations is the most specific for confirming the suspected diagnosis?

An 18-month-old boy is brought to the primary care clinic by his mother for a routine check-up. She expresses concern that he has been more irritable and less active than usual. His diet consists primarily of whole cow's milk (approximately 1 litre/day). On examination, he is pale. Initial lab results show a haemoglobin of 9.2 g/dL, an MCV of 68 fL, a high RDW of 18.0%, and a normal reticulocyte count. Iron deficiency anaemia is strongly suspected. Which of the following laboratory tests is the most specific for confirming the suspected diagnosis?